{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T20:33:59Z","timestamp":1786480439879,"version":"build-2736575974"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82460686"],"award-info":[{"award-number":["82460686"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031918","name":"State Key Laboratory of Natural and Biomimetic Drugs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031918","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010828","name":"Department of Education of Guizhou Province","doi-asserted-by":"publisher","award":["Qianjiaoji [2023] 069"],"award-info":[{"award-number":["Qianjiaoji [2023] 069"]}],"id":[{"id":"10.13039\/501100010828","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.bioorg.2025.109395","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T16:44:26Z","timestamp":1765903466000},"page":"109395","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Synthesis of trifluoromethyl-containing spiro-epoxyindole-pyrrolidines via a DABCO-catalyzed [3\u00a0+\u00a02] cycloaddition and their antitumor activities"],"prefix":"10.1016","volume":"169","author":[{"given":"Yang","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang-Liang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-Ping","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang-Chao","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Juan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiong-Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo-Wen","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.109395_bb0005","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1279822","article-title":"Advances in the role of micrornas associated with the Pi3k\/Akt signaling pathway in lung cancer","volume":"13","author":"Wang","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bioorg.2025.109395_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2016.12.007","article-title":"Proteasome inhibitors in cancer therapy: treatment regimen and peripheral neuropathy as a side effect","volume":"103","author":"Kaplan","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bioorg.2025.109395_bb0015","article-title":"Targeted therapies for glioblastoma treatment","volume":"74","author":"Smolarska","year":"2023","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.109395_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106425","article-title":"Recent development of multi-target Vegfr-2 inhibitors for the Cancer therapy","volume":"133","author":"Liu","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109395_bb0025","first-page":"15","article-title":"Inhibition of Rna polymerase iii augments the anti-Cancer properties of Tnf\u03b1","author":"Nair","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bioorg.2025.109395_bb0030","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12943-023-01826-7","article-title":"Reigniting Hope in Cancer treatment: the promise and pitfalls of Il-2 and Il-2r targeting strategies","volume":"22","author":"Muhammad","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bioorg.2025.109395_bb0035","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202300185","article-title":"Synthesis and Sars study of novel Spiro-Oxindoles as potent Antiproliferative agents with Cdk-2 inhibitory activities","volume":"356","author":"Al-Jassas","year":"2023","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.bioorg.2025.109395_bb0040","doi-asserted-by":"crossref","first-page":"5223","DOI":"10.1073\/pnas.1819303116","article-title":"Cox-2 mediates tumor-stromal prolactin signaling to initiate tumorigenesis","volume":"116","author":"Zheng","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bioorg.2025.109395_bb0045","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202200263","article-title":"Structure-activity relationship study to improve cytotoxicity and selectivity of Lonafarnib against breast Cancer cells","volume":"356","author":"Hongnak","year":"2023","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.bioorg.2025.109395_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23041998","article-title":"New insights on the nuclear functions and targeting of Fak in Cancer","volume":"23","author":"Pomella","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.109395_bb0055","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1021\/np200391c","article-title":"The relevance of higher plants in Lead compound discovery programs","volume":"74","author":"Kinghorn","year":"2011","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bioorg.2025.109395_bb0060","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1021\/np200906s","article-title":"Natural products as sources of new drugs over the 30 years from 1981 to 2010","volume":"75","author":"Newman","year":"2012","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bioorg.2025.109395_bb0065","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.biotechadv.2015.08.001","article-title":"Discovery and resupply of pharmacologically active plant-derived natural products: a review","volume":"33","author":"Atanasov","year":"2015","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.bioorg.2025.109395_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155925","article-title":"The Phthalide compound Tokinolide B from Angelica Sinensis exerts anti-inflammatory effects through Nur77 binding","volume":"133","author":"Xia","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bioorg.2025.109395_bb0075","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1021\/jo9622542","article-title":"Four new C19 Homolignans, Schiarisanrins a, B, and D and cytotoxic Schiarisanrin C, from Schizandra Arisanensis","volume":"62","author":"Kuo","year":"1997","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bioorg.2025.109395_bb0080","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3727\/096504022X16427607626672","article-title":"Real-world data: Fruquintinib in treating metastatic colorectal Cancer","volume":"29","author":"Liu","year":"2022","journal-title":"Oncol. Res."},{"key":"10.1016\/j.bioorg.2025.109395_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2019.103937","article-title":"Evolution of rifampicin treatment for tuberculosis","volume":"74","author":"Grobbelaar","year":"2019","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.bioorg.2025.109395_bb0090","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s40263-016-0330-y","article-title":"Tasimelteon: a review in Non-24-hour sleep-wake disorder in totally blind individuals","volume":"30","author":"Keating","year":"2016","journal-title":"CNS Drugs"},{"key":"10.1016\/j.bioorg.2025.109395_bb0095","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1021\/acsinfecdis.6b00041","article-title":"Therapeutic potential of Spirooxindoles as antiviral agents","volume":"2","author":"Ye","year":"2016","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.bioorg.2025.109395_bb0100","doi-asserted-by":"crossref","first-page":"7223","DOI":"10.1021\/ja3125417","article-title":"Diastereomeric Spirooxindoles as highly potent and efficacious Mdm2 inhibitors","volume":"135","author":"Zhao","year":"2013","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2025.109395_bb0105","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jphotobiol.2018.01.026","article-title":"Regio- and Stereoselective synthesis of new Spirooxindoles via 1,3-dipolar cycloaddition reaction: anticancer and molecular docking studies","volume":"180","author":"Lotfy","year":"2018","journal-title":"J. Photochem. Photobiol. B"},{"key":"10.1016\/j.bioorg.2025.109395_bb0110","doi-asserted-by":"crossref","first-page":"8294","DOI":"10.1002\/anie.201309260","article-title":"Trifluoromethylation of alkenes with concomitant introduction of additional functional groups","volume":"53","author":"Egami","year":"2014","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.bioorg.2025.109395_bb0115","doi-asserted-by":"crossref","first-page":"6607","DOI":"10.1039\/C8CC02364F","article-title":"Catalytic asymmetric synthesis of Spirooxindoles: recent developments","volume":"54","author":"Mei","year":"2018","journal-title":"Chem. Commun. (Camb.)"},{"key":"10.1016\/j.bioorg.2025.109395_bb0120","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1039\/C5OB02278A","article-title":"Catalytic asymmetric [3 + 2]-cycloaddition for Stereodivergent synthesis of chiral Indolyl-Pyrrolidines","volume":"14","author":"Arai","year":"2016","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.bioorg.2025.109395_bb0125","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1002\/asia.202000054","article-title":"Recent advances in the construction of Trifluoromethyl-containing Spirooxindoles through cycloaddition reactions","volume":"15","author":"Gui","year":"2020","journal-title":"Chem. Asian J."},{"key":"10.1016\/j.bioorg.2025.109395_bb0130","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1002\/adsc.201500416","article-title":"The Squaramide-catalyzed 1,3-dipolar cycloaddition of Nitroalkenes with N-2,2,2-Trifluoroethylisatin Ketimines: an approach for the synthesis of 5\u2032-Trifluoromethyl-Spiro[pyrrolidin-3,2\u2032-oxindoles]","volume":"357","author":"Sun","year":"2015","journal-title":"Adv. Synth. Catal."},{"key":"10.1016\/j.bioorg.2025.109395_bb0135","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1039\/C9QO00241C","article-title":"Highly efficient enantioselective synthesis of Bispiro[benzofuran-oxindole-pyrrolidine]s through Organocatalytic cycloaddition","volume":"6","author":"Li","year":"2019","journal-title":"Org. Chem. Front."},{"key":"10.1016\/j.bioorg.2025.109395_bb0140","doi-asserted-by":"crossref","first-page":"4484","DOI":"10.1021\/cr050011g","article-title":"Construction of Enantiopure Pyrrolidine ring system via asymmetric [3+2]-cycloaddition of Azomethine Ylides","volume":"106","author":"Pandey","year":"2006","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioorg.2025.109395_bb0145","doi-asserted-by":"crossref","first-page":"20750","DOI":"10.1021\/ja2100356","article-title":"Stereodivergency in catalytic asymmetric conjugate addition reactions of Glycine (Ket)imines","volume":"133","author":"Kim","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2025.109395_bb0150","doi-asserted-by":"crossref","first-page":"7895","DOI":"10.1002\/anie.201004098","article-title":"Catalytic asymmetric Exo'-selective [3 + 2] cycloaddition of Iminoesters with Nitroalkenes","volume":"49","author":"Arai","year":"2010","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.bioorg.2025.109395_bb0155","doi-asserted-by":"crossref","first-page":"5151","DOI":"10.1021\/jm3001289","article-title":"Rational evolution of a novel type of potent and selective Proviral integration site in Moloney murine leukemia virus kinase 1 (Pim1) inhibitor from a screening-hit compound","volume":"55","author":"Nakano","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109395_bb0160","doi-asserted-by":"crossref","DOI":"10.1002\/aoc.4995","article-title":"Tin powder promoted synthesis of Trifluoroethylamine-containing 3,3'-Disubstituted Oxindoles","volume":"33","author":"Wang","year":"2019","journal-title":"Appl. Organomet. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825012751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825012751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T20:20:58Z","timestamp":1786479658000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825012751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":32,"alternative-id":["S0045206825012751"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109395","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis of trifluoromethyl-containing spiro-epoxyindole-pyrrolidines via a DABCO-catalyzed [3\u00a0+\u00a02] cycloaddition and their antitumor activities","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109395","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109395"}}